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Background: Approximately 40%–45% of youth with anxiety disorders do not achieve remission (or a substantial
reduction in symptoms) following treatment, highlighting the need to identify predictors of treatment response. Given
the well-established link between attentional biases and anxiety disorders in youth and adults, this study examined
the neural correlates of directing attention toward and away from emotional faces in relation to pediatric anxiety
treatment response. Method: Prior to beginning treatment with the selective serotonin reuptake inhibitor (SSRI)
sertraline or cognitive behavior therapy (CBT), 37 youth (age 7–19 years) with generalized and/or social anxiety
disorder completed a task with conditions that manipulated whether participants were instructed to match
emotional faces (explicit emotion processing) or match shapes in the context of emotional face distractors (implicit
emotion processing) during functional magnetic resonance imaging. Results: Results revealed that reduced
activation in superior frontal gyrus (SFG), encompassing the dorsal anterior cingulate cortex (ACC) and dorsomedial
prefrontal cortex (PFC), during implicit processing of emotional faces predicted a greater reduction in anxiety severity
pre-to-post treatment. Post hoc analyses indicated that effects were not significantly moderated by the type of
treatment or anxiety type. Conclusions: Findings suggest that less recruitment of SFG, including the dorsal ACC and
dorsomedial PFC, during implicit emotion processing predicts a greater reduction in youth anxiety symptoms pre-to-
post treatment. Youth who exhibit reduced activation in these areas while matching shapes in the context of
emotional face distractors may have more to gain from CBT and SSRI treatment due to preexisting deficits in
attentional control. These findings suggest that neuroimaging may be a useful tool for predicting which youth are
most likely to benefit from anxiety treatment. Keywords: Pediatric anxiety; treatment response; neuroimaging;
attention; emotion processing.
Introduction
Pediatric anxiety disorders, affecting approximately
10%–15% of children and adolescents (Costello,
Mustillo, Erkanli, Keeler, & Angold, 2003), are one
of the most common classes of psychological disor-
ders in youth and are associated with impairment in
social and academic functioning, and increased risk
of multiple disorders later in life (Mychailyszyn,
Mendez, & Kendall, 2010). Although pediatric anx-
iety can be treated effectively through the use of
cognitive behavioral therapy (CBT) and pharmaco-
logical treatments [i.e. selective serotonin reuptake
inhibitors (SSRIs)], approximately 40%–45% of
youth do not achieve remission or a substantial
reduction in symptoms (Mohatt, Bennett, & Walkup,
2014). Identifying predictors of outcome may allow
clinicians to identify youth at risk for poorer out-
comes and help guide patients toward those treat-
ments with the highest likelihood of success.
Cognitive models of anxiety suggest that individu-
als’ characteristic ways of attending to threatening
stimuli contribute to the development, maintenance,
and treatment of the disorder (e.g. Clark, Beck, &
Alford, 1999). Supporting these models, studies
demonstrate that anxiety disorders in children and
adults are characterized by both initial orienting of
attention to threatening (angry or fearful) stimuli and
difficultly diverting attention from threatening stim-
uli (e.g. Bar-Haim, Lamy, Pergamin, Bakermans-
Kranenburg, & Van Ijzendoorn, 2007; Bishop, 2007;
Pine, 2007). Studies investigating the neural corre-
lates of these attentional responses in anxiety high-
light overactivation of regions associated with the
detection of threat, such as the amygdala, and
altered top-down control by regions associated with
goal-directed attention, such as the lateral prefrontal
cortex (PFC) and anterior cingulate cortex (ACC)
(Bishop, 2007). Engagement of the ACC, in particu-
lar, appears to be critical in maintaining an appro-
priate balance between sensitivity to potential threat
and carrying out task-relevant cognitive goals (i.e.
directing attention away from threat) (Etkin, Egner,
Peraza, Kandel, & Hirsch, 2006).
Notably, anxious youth (Beesdo et al., 2009;
Guyer et al., 2008) and adults (Etkin & Wager,
2007) exhibit increased amygdala reactivity when
performing tasks with threatening stimuli and lessConflict of interest statement: No conflicts declared.
© 2016 Association for Child and Adolescent Mental Health.
Published by John Wiley & Sons Ltd, 9600 Garsington Road, Oxford OX4 2DQ, UK and 350 Main St, Malden, MA 02148, USA
Journal of Child Psychology and Psychiatry 58:5 (2017), pp 546–554 doi:10.1111/jcpp.12658
activation in the ACC while performing tasks that
require participants to direct their attention away
from emotional stimuli (Bishop, Duncan, Brett, &
Lawrence, 2004; Klumpp et al., 2011). Moreover, in
a task developed in our laboratory, we had previ-
ously shown that when participants are instructed to
match emotional faces (explicit emotion processing)
or match shapes in the context of emotional face
distractors (implicit emotion processing), both youth
(Swartz et al., 2014) and adults (Klumpp, Post,
Angstadt, Fitzgerald, & Phan, 2013) with anxiety
disorders, compared with healthy controls, exhibit
less ACC activation during implicit versus explicit
matching.
While these previous studies have generally been
consistent in supporting this neuropathophysiolog-
ical model in anxiety disorders (i.e. enhanced amyg-
dala activation during explicit emotion processing
and decreased prefrontal activation when required to
direct attention away from emotional stimuli), sur-
prisingly few studies have examined how neural
correlates of these processes relate to anxiety treat-
ment outcome. In one study of adults with social
anxiety disorder, greater activation of the dorsal ACC
during implicit emotion processing (i.e. matching
shapes in the context of emotional face distractors)
predicted better response to CBT (Klumpp, Fitzger-
ald, Angstadt, Post, & Phan, 2014). However, only
two previous fMRI studies have examined predictors
of treatment response in youth with anxiety disor-
ders, and both of these studies focused solely on
explicit emotion processing. In one study, greater
amygdala activation in response to viewing fearful
faces predicted better treatment response among a
sample of anxious youth (McClure et al., 2007). More
recently, using a different task that probed explicit
emotional processing only, we found that greater
activation in dorsolateral and ventrolateral PFC
while processing threatening faces predicted greater
response to CBT and SSRI treatment (Kujawa,
Swain, et al., 2016).
The primary aim of this study was to extend these
previous studies by examining neural correlates of
both explicit and implicit emotion processing in
relation to treatment outcome for pediatric anxiety.
This two-site study was modeled after the Child/
Adolescent Anxiety Multimodal Study (Compton
et al., 2010) in that it included children and
adolescents across a large span of development
(7–19 years) with primary diagnoses of generalized
anxiety disorder (GAD) and/or social anxiety disor-
der (SAD), two of the most common anxiety disorders
in youth (Mohatt et al., 2014), treated with either
sertraline (i.e. SSRI) or psychotherapy (i.e. CBT).
Prior to treatment, participants completed the Emo-
tional Faces Shifting Attention Task (EFSAT;
Klumpp, Angstadt, & Phan, 2012; Klumpp et al.,
2013, 2014; Swartz et al., 2014) in which images
comprising a trio of geometric shapes (circles, rect-
angles, triangles) were presented alongside a trio of
emotional facial expressions (angry, fearful, happy),
and the participant was prompted to match either
faces or shapes. The task provides a measure of
neural correlates of both explicit and implicit emo-
tional processing, as the instruction to ‘Match
Shapes’ requires participants to direct attention
away from emotional faces, whereas ‘Match Faces’
requires individuals to direct attention toward emo-
tional faces.
Based on the findings that patients with anxiety
disorders exhibit less ACC recruitment in the pres-
ence of angry, fearful, or happy face distractors (i.e.
Match Shapes > Match Faces; Klumpp et al., 2013;
Swartz et al., 2014), we expected that recruitment of
the ACC during implicit emotion processing (Match
Shapes) would influence response to treatment.
Regarding the direction of this effect, although we
previously demonstrated that greater dorsal ACC
activation during implicit processing predicts better
response to CBT among anxious adults (Klumpp
et al., 2014), studies examining attentional biases in
children at the behavioral level suggest the opposite
pattern. For example, children who experience diffi-
culty diverting their attention away from threat-
relevant stimuli, perform better with CBT (Waters,
Mogg, & Bradley, 2012). This finding is consistent
with studies suggesting that attentional biases
improve with anxiety treatment (Pishyar, Harris, &
Menzies, 2008) and that the therapeutic effects of
anxiety treatment are mediated by early changes in
attentional bias (Abend & Bar-Haim, 2013). Because
of these mixed findings, no specific hypotheses were
generated regarding the direction of the ACC
response during implicit emotion processing and its
relation to treatment response in youth with anxiety.
Regarding explicit emotion processing (Match
Faces), consistent with the two previous pediatric
anxiety treatment outcome studies (cf. Kujawa,
Swain, et al., 2016; McClure et al., 2007), we pre-
dicted that greater activation of the dorsolateral and
ventrolateral PFC and the amygdala would be related
to better anxiety treatment response.
Methods
Participants
Participants were part of a pediatric anxiety treatment study at
the University of Michigan (UM) and the University of Illinois at
Chicago (UIC). Participants in the study were youth between
the ages of 7 and 19 with primary diagnoses of GAD or social
anxiety disorder. The Schedule of Affective Disorders and
Schizophrenia for School-Age Children (Kaufman et al., 1997)
diagnostic interview was used to assess for diagnoses by
master’s- or doctoral-level clinicians (see Kujawa, MacNamara,
Fitzgerald, Monk, & Phan, 2015 for more details). Exclusion
criteria included history of bipolar disorder, schizophrenia,
intellectual disability, pervasive development disorders, cur-
rent substance use disorders, severe depression, or suicidal
ideation. Participants with secondary comorbid anxiety,
depressive, or externalizing disorders were included in the
study (see Participant Characteristics). Participants were not
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taking psychotropic medications or in psychotherapy for at
least 4 weeks prior to the initial assessment.
A total of 44 anxious youth completed the fMRI Emotional
Faces Shifting Attention Task (EFSAT), followed by a minimum
of 10 weeks of pharmacotherapy or psychotherapy. Data from
six participants were excluded for movement during the fMRI
(>3 mm in any one direction across each functional run) and
one participant was excluded for low accuracy on the task
(<20%), leaving a total sample of 37 youth with pretreatment
fMRI and pre- and posttreatment clinical measures (n = 21
who received SSRI treatment; n = 16 who received CBT treat-
ment). The included sample was 59.5% female; 73.0% Cau-
casian, 8.1% African American, 5.4% Asian, and 13.5%
multiracial; 10.8% identified as Hispanic/Latino.
Procedure
Procedures were approved by the institutional review boards
at both UIC and UM. Participants completed the clinical
interview and pretreatment symptom measures during the
initial visit. Participants then completed the fMRI scan (within
1 week of initial interview). At UM, participants were offered
and self-selected treatment with SSRI or CBT. At UIC,
participants were initially randomly assigned to receive either
an SSRI or CBT, but could opt to switch from SSRI to CBT
due to intolerable side effects. SSRI treatment consisted of
12 weeks of sertraline prescribed by a child psychiatrist
during medication management sessions, beginning with a
dose of 12.5 or 25 mg/day and in a flexible-dosing design
increasing on subsequent visits up to 200 mg/day based on
tolerability and treatment response. CBT was delivered
through weekly 60-minute sessions (up to a maximum of 18
sessions) by a master’s- or doctoral-level therapist. Treatment
followed an established manualized CBT intervention (i.e.
CopingCat,C.A.T Project) for pediatric anxiety (Kendall, Choud-
hury, Hudson, & Webb, 2002; Kendall & Hedtke, 2006).
Measures
Emotional faces shifting attention task (EFSAT;
Klumpp et al., 2012, 2013, 2014; Swartz et al.,
2014). A trial of the EFSAT consists of three faces in a
triangular configuration, and three shapes in an upside-down
triangular configuration (Figure 1). During the faces condition,
participants were instructed to identify which face on the
bottom row matched the emotion of the target face on the top.
During the shapes condition, participants were instructed to
match shapes on the top row with the target shape on the
bottom. Participants completed two runs, for a total of 18 faces
blocks and 18 shapes blocks with six blocks of each condition:
match angry faces, fear faces, and happy faces, and match
shapes with angry faces, fear faces, and happy faces as
distractors. Each block began with a 4-s cue to either match
faces or match shapes followed by the four sequential match-
ing trials, each lasting 4 s.
fMRI data acquisition and processing. MRI data
were collected on 3 Tesla GE scanners with 8-channel head
coils at both sites. At UM, functional data were collected with a
gradient-echo reverse spiral acquisition with the following
parameters: repetition time (TR) = 2 s, echo time (TE) = 30 ms,
flip angle = 90, field of view (FOV) = 22 9 22 cm, acquisition
matrix 64 9 64, 3-mm slice thickness, and 43 axial slices. At
UIC, functional data were acquired using gradient-echo echo-
planar imaging (EPI) sequence with the following parameters:
TR = 2 s, TE = minFull [~25 ms], flip angle = 90,
FOV = 22 9 22 cm, acquisition matrix 64 9 64, 3-mm slice
thickness, and 44 axial slices.
Functional images were preprocessed in SPM8 (Wellcome
Trust Centre for Neuroimaging, http://www.fil.ion.ucl.ac.uk/
spm/) for slice timing correction, image normalization, and
resampling at a 2 9 2 9 2 mm3 voxel size and 8-mm Gaussian
smoothing kernel. Condition effects were modeled at the
individual subject level using the general linear model, and
the nuisance regressors for six motion parameters were
included to correct for motion artifacts. For each participant,
contrast images of brain activity were generated for second-
level analysis.
Response to treatment. To assess severity of anxiety
symptoms at pre- and posttreatment, participants were
administered the Pediatric Anxiety Rating Scale (PARS;
Research Units, 2002). The PARS was completed at the initial
screening visit and at the final treatment session. Greater
PARS change scores (i.e. pretreatment minus posttreatment)
indicate greater response to treatment.
Data analysis
Consistent with previous studies in our laboratory using the
EFSAT task to predict treatment response (Klumpp et al.,
2014), a one-sample t-test with change in PARS scores as a
covariate of interest was performed in SPM8 for the March
Face > Match Shape contrast. To control for methodological
and demographic variables, site/scanner (UM or UIC), treat-
ment (SSRI or CBT), and age were included as covariates in the
second-level analysis. Based on a priori regions of interest from
our hypotheses, we focused on the bilateral amygdala and the
dorsolateral and ventrolateral PFC using the Wake Forest
University Pickatlas (WFU Pickatlas) (Maldjian, Laurienti,
Kraft, & Burdette, 2003). In order to obtain an ROI for the
rostral portion of the ACC, the Anterior Cingulate Region was
intersected with the medial frontal region (Swartz et al., 2014)
defined by the Automated Anatomical Labeling (AAL) atlas.
Activations were deemed as significant using small-volume
correction (SVC) and family-wise error (FWE) corrected p < .05.
For completeness, we also examine activation clusters outside
a priori ROIs at the whole-brain level using FWE correction at
p < .05.
Exploratory analyses were conducted to investigate emo-
tion-specific effects. Specifically, activation (beta weights) from
a 10-mm diameter sphere around peak voxels surviving small-
volume correction and FWE (ROI regions) for the Match
Figure 1 Schematic of exemplar ‘Match Faces’ and ‘Match
Shapes’ blocks in the Emotional Faces Shifting Attention Task
(EFSAT). Trials were presented in block format, and participants
were instructed at the beginning of each block to either match
faces or match shapes for that block. The match faces condition
requires attending to the emotional faces, whereas the match
shapes condition requires performing the shape-matching task in
the context of emotional face distractors [Colour figure can be
viewed at wileyonlinelibrary.com]
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Face > Match Shape contrast were extracted using MarsBar
(Brett, Anton, Valabregue, & Poline, 2002) and exported into
SPSS for the separate emotion contrasts: Match
Shape[Angry] > Match Face[Angry], Match Shape[Fear] > Match
Face[Fear], and Match Shape[Happy] > Match Face[Happy]. In
SPSS, a generalized linear model was then conducted with
activation for each emotion type (angry, fear, and happy)
serving as the within-subject variables and PARS pre-to-post
change, site/scanner (UM or UIC), treatment (SSRI or CBT),
and age as continuous between-subjects variables. Green-
house-Geisser corrections were used in cases in which the
sphericity assumption was violated and Bonferroni procedures
were used to correct for multiple comparisons.
Results
Participant characteristics
With regard to clinical disorders, 67.6% of the
sample had current diagnoses of GAD, 59.5% SAD,
and 10.8% separation anxiety disorder. In addition,
10.8% had comorbid separation anxiety disorder,
10.8% panic disorder, 2.7% obsessive-compulsive
disorder, 18.9% specific phobia, 5.4% depression,
and 16.2% ADHD. Anxiety severity (i.e. PARS)
decreased following treatment, t(36) = 14.07, p <
.001, mean difference = 13.54. With regard to treat-
ment response, 79.1% of the sample responded to
treatment and 69.8% showed evidence of remission,
as indicated by at least a 35% and 50% decrease in
PARS, respectively (Caporino et al., 2013).
Participant characteristics by treatment group are
presented in Table 1. CBT and SSRI groups did not
significantly differ on PARS, age, or distribution of
sex, race, IQ, or primary diagnosis (ps > .13); how-
ever, the CBT group completed more sessions than
the SSRI group, t(35) = 5.15, p < .001. Study sites
did not significantly differ on treatment modality
(UM: n = 10 CBT, n = 11 SSRI; UIC: n = 6 CBT,
n = 10 SSRI), PARS posttreatment or change, age,
number of sessions, or primary diagnoses (ps > .09).
Compared with the sample recruited at UM, the UIC
sample had greater pretreatment PARS scores,
t(35) = 2.72, p = .01, and included a greater
proportion of males, v2(1) = 5.64, p = .02, and
participants who identified as Hispanic/Latino,
v2(1) = 5.89, p = .05.
Behavioral performance
Behavioral data were lost for one participant due to a
technical error. To examine the influence of emotion
(angry, fear, and happy) and condition (shapes vs.
faces) on accuracy and RT, a repeated-measures
ANOVA was conducted. Results revealed a main
effect of condition, F(1, 34) = 13.64, p < .001, with
accuracy being higher for matching shapes
(M = 84.92, SE = 2.10) compared with matching
faces (M = 79.22, SE = 2.31) across participants.
There was also a main effect of condition for RT,
F(1, 34) = 32.83, p < .001, with slower responses
when matching faces (M = 1625.06, SE = 98.17)
compared with matching shapes (M = 1269.11,
SE = 92.15). None of the other main effects or
interactions were significant for accuracy or RT
(lowest p = .09).
fMRI predictors of treatment response
Results of the ROI one-sample t-test revealed that
lower activation of superior frontal gyrus [(12, 54, 20),
t-value = 3.47, volume = 2,896 mm3, svccorrected
p = .03] – a large cluster encompassing the dorsal
ACC and ventromedial PFC – during the Match
Shape > Match Face contrast predicted a greater
reduction in anxiety symptoms pre-to-post
treatment. No other regions outside the SFG were
associated with change in symptoms for the Match
Shape > Match Face contrast within ROIs or for the
whole-brain analysis.
Exploratory analyses were then conducted to
examine emotion-specific effects. We extracted beta
weights from a spherical ROI around the peak voxel
for the SFG cluster (12 54 20) for the Match
Shape[Angry] > Match Face[Angry], Match Shape[Fear] >
Match Face[Fear], and Match Shape[Happy] > Match
Face[Happy] contrasts. A generalized linear model was
then conducted with SFG activation for each emotion
Table 1 Participant characteristics by treatment group [selec-
tive serotonin reuptake inhibitor (SSRI) or cognitive behavioral
therapy (CBT)] and study site [University of Michigan (UM) or
University of Illinois at Chicago (UIC)]
SSRI (n = 21) CBT (n = 16)
Mean SD Mean SD
Age 14.43 2.87 14.50 3.03
Number of sessions 11.90 0.44 14.87 2.60
Pretreatment PARS 23.62 5.06 22.13 3.40
Posttreatment PARS 9.57 5.72 9.25 6.18
PARS change 14.05 6.31 12.88 5.32
WASI IQ estimate 110.41 11.24 109.38 11.98
N % N %
Female 11 52.4 11 68.8
Primary GAD 12 57.1 9 56.3
Primary social anxiety disorder 9 42.9 7 43.8
UM (n = 21) UIC (n = 16)
Mean SD Mean SD
Age 14.09 2.79 14.94 3.07
Number of sessions 12.81 1.94 13.69 2.63
Pretreatment PARS 21.38 4.14 25.06 4.01
Posttreatment PARS 7.90 5.61 11.44 5.69
PARS change 13.48 6.35 13.63 5.33
WASI IQ estimate 110.76 11.34 109.00 11.83
N % N %
Gender (Female) 16 76.2 6 37.5
Primary GAD 13 61.9 8 50.0
Primary social anxiety disorder 8 38.1 8 50.0
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type (angry, fear, and happy) serving as the within-
subject variables and PARS pre-to-post change, site/
scanner (UM or UIC), treatment (SSRI or CBT), and
age as continuous between-subjects variables.
Results revealed a significant Emotion 9 PARS pre-
to-post Change interaction for SFG activation, F(2,
31) = 3.35, p = .04, np2 = .10. To follow-up this
interaction, partial correlations between SFG activa-
tion for each emotion type and PARS pre-to-post
change were calculated controlling for treatment
modality, site, and age. Results revealed a significant
negative correlation between PARS pre-to-post
change and SFG activation for the Match
Shape[Fear] > Match Face[Fear] contrast (r = .47,
p < .01; Figure 2). No significant relations with PARS
pre-to-post change were observed for the
Match Shape[Angry] > Match Face[Angry] or Match
Shape[Happy] > Match Face[Happy] contrasts (lowest
p = .12). The correlation between PARS pre-to-post
change and SFG activation for the Match
Shape[Fear] > Match Face[Fear] contrast remained sig-
nificant after adjusting for youth’s initial anxiety
symptom severity, (PARSPreTx), r = .39, p = .02 and
IQ (WASI), r = .41, p = .02. None of the interactions
with participant’s age and gender, study site, and
treatment were significant (lowest p = .09). We also
examined whether participant’s primary anxiety
diagnosis moderated the relation between SFG acti-
vation during implicit fear processing and treatment
response; none of these analyses were significant
(lowest p = .21).
Finally, because the shapes > faces contrast can
be interpreted as decreased activation when match-
ing shapes (implicit emotion processing) or increased
activation when matching faces (explicit emotion
processing), we extracted beta weights from a spher-
ical ROI around the peak voxel for the SFG for Match
Shape[Fear] > Baseline (activation across all condi-
tions) and Match Face[Fear] > Baseline contrasts.
Partial correlations in SPSS between brain activation
and PARS pre-to-post change were then calculated
controlling for age, treatment modality, and site. As
shown in Figure 2, SFG activation during implicit
fear processing was negatively correlated with PARS
pre-to-post change (r = .38, p = .02); however, the
Match Face[Fear] > Baseline contrast was not related
to PARS change (r = .12, p = .48).
Discussion
This study used fMRI to examine potential brain
predictors of treatment response for pediatric anxi-
ety. Given the well-established link between atten-
tional biases and anxiety disorders, (e.g. Bar-Haim
et al., 2007; Bishop, 2007; Pine, 2007), this study
examined the neural correlates of directing attention
toward (explicit emotion processing) and away (im-
plicit emotion processing) from emotional stimuli in
relation to pediatric anxiety treatment response.
Results revealed that reduced activation in SFG,
encompassing the dorsal ACC and dorsomedial PFC,
during implicit emotion processing predicted a
Figure 2 Exploratory analyses findings showing that reduced superior frontal gyrus, including the dorsal anterior cingulate cortex and
dorsomedial prefrontal cortex, activation during processing of shapes in the context of fearful face distractors predicted greater change
in anxiety severity, measured via the Pediatric Anxiety Rating Scale, pretreatment to posttreatment. Association between anxiety
symptom change, measured via the Pediatric Anxiety Rating Scale, pre-to-post treatment and superior frontal gyrus (SFG) activation
(mean blood–oxygen-level-dependent parameter estimates; a.u. = arbitrary units) during (A) Match Shapes [Fear] > Match Faces [Fear], (B)
Match Shape [Fear] > Baseline (Implicit Processing), and (C) Match Faces [Fear] > Baseline (Explicit Processing)
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greater reduction in anxiety severity pre- to post-
treatment. Exploratory analyses revealed that this
effect appeared to be driven by implicit fear process-
ing and was not observed for matching faces in the
context of happy or angry face distractors. We found
no evidence for these effects being moderated by
type of treatment or primary diagnosis, suggesting
similar effects across SSRI and CBT interventions,
as well as diagnoses of GAD and social anxiety
disorder.
The ACC plays a crucial role in attention-emotion
processes (Bush, Luu, & Posner, 2000; Carter et al.,
1998), and the dorsal ACC, in particular, has been
linked to conflict monitoring and cognitive appraisal
processes (Etkin, Egner, & Kalisch, 2011). In chil-
dren and adults with anxiety, the ACC has been
linked to ability to direct attention away from stimuli
when threatening material is presented (e.g. Bishop
et al., 2004; Klumpp et al., 2011, 2012; Swartz
et al., 2014). Thus, children who recruit less dorsal
ACC during attempts to process shapes when emo-
tional stimuli are presented may have more to gain
from CBT and SSRI treatment due to preexisting
deficits in attentional control and implicit regulatory
ability. This interpretation is consistent with recent
evidence that the therapeutic effects of anxiety
treatment are mediated by early changes in atten-
tional bias (Abend & Bar-Haim, 2013) and from
behavioral studies suggesting that attentional con-
trol improves with anxiety treatment (Pishyar et al.,
2008). In addition, the current findings parallel
recent research using a dot-probe task with children
suggesting that anxious youth who exhibit pretreat-
ment attention biases toward threatening stimuli
show greater reductions not only in anxiety symptom
severity but also in the likelihood of meeting diag-
nostic criteria for anxiety disorders following treat-
ment (Waters et al., 2012). These findings provide
preliminary evidence at the neural level that youth
who recruit less ACC during attempts to direct their
attention away from emotional stimuli may benefit
the most from anxiety treatment, potentially due to
having more to gain in treatment. Future studies are
needed to determine whether activation of ACC
during the processing of neutral information in the
context of emotional distractors improves pre-to-
post treatment among youth with anxiety disorders.
Notably, we previously demonstrated in adults
that greater dorsal ACC during implicit emotion
processing was related to greater anxiety symptom
reduction following CBT (Klumpp et al., 2014). One
possible explanation for the discrepant findings is
that the current sample focused on response to both
CBT and SSRI treatment, whereas the previous adult
study focused solely on response to CBT. Impor-
tantly, previous studies suggest that distinct pat-
terns of ACC activation (i.e. hypo vs. hyper) may
predict response to CBT versus medication in
depression (Ball, Stein, & Paulus, 2014); thus, it is
possible that current findings are primarily driven by
those treated with SSRI and our analyses may be
underpowered to detect differences between the two
treatments. Alternatively, there may be differences in
the direction of ACC activation depending on age and
development. For example, recent work suggests
that anxiety is characterized by altered developmen-
tal patterns of amygdala connectivity with ACC from
childhood into young adulthood (Kujawa, Wu, et al.,
2016). In addition, a separate study shows that age
moderates the link between anxiety and the error-
related negativity, an event-related potential compo-
nent that is generated in the ACC (Meyer, Weinberg,
Klein, & Hajcak, 2012). Among older children, a
larger ERN is significantly related to increased
anxiety; however, the relationship between ERN
and anxiety appears to be opposite among younger
children. Thus, it will be important for future, larger
studies to examine how developmental differences
impact the relation between ACC activation during
emotion processing and treatment response.
Decreased dorsomedial PFC activation during
implicit emotion processing also predicted a signif-
icant reduction in anxiety symptoms pre-to-post
treatment. The dorsomedial PFC is part of an
extended medial prefrontal network involved in
assessing the value and valence of stimuli and
generating adaptive responses that guide behavior
(Etkin et al., 2011; Price & Drevets, 2010). Thus,
decreased recruitment of this specific region in
response to disengaging from emotional information
suggests that some individuals may have been more
likely to improve if they had a reduced capacity to
regulate their responses when attempting to direct
their attention away from the emotional stimuli prior
to beginning treatment.
This study extends previous work on pediatric
anxiety treatment response by examining the influ-
ence of implicit emotion processing. The two previ-
ous studies utilizing fMRI to examine predictors of
anxiety treatment outcome focused solely on explicit
emotion processing and found that greater amygdala
(McClure et al., 2007) and dorsolateral and ventro-
lateral PFC (Kujawa, Swain, et al., 2016) activation
in response to viewing threatening faces predicted
better treatment response among anxious youth. In
this study, exploratory post hoc analyses revealed
that treatment response was significantly related to
ACC activation during implicit, but not explicit, fear
processing. However, the baseline contrast used in
these analyses reflects average activation across the
entire task, which involves explicit emotion process-
ing. Therefore, future research would benefit from
including a separate neutral condition (e.g. ‘match
houses’) in the EFSAT task to more definitively test
whether ACC activation is specific to explicit versus
implicit processing in relation to pediatric anxiety
treatment response.
Results from this study also showed that the
majority of the current sample (79.1%) showed a
35% or greater reduction in PARS severity, which
© 2016 Association for Child and Adolescent Mental Health.
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has been associated with treatment response
(Caporino et al., 2013). This is noteworthy as this
response rate is higher than rates reported in large
randomized controlled trials of CBT and SSRI in
anxious youth (e.g. Walkup et al., 2008). This is
likely due to the current study only including youth
who completed treatment, the fMRI scan, and had
pre- and posttreatment clinical measures. Future
research is needed to evaluate whether neural mea-
sures may be useful in predicting treatment engage-
ment and tolerability in children and adolescents
with anxiety disorders.
The current findings should be interpreted in the
context of several limitations. First, the small sample
size may have limited our ability to detect modera-
tors (i.e. age, sex, and treatment type) of treatment
response. Second, the study sample is heteroge-
neous with regard to primary diagnoses; although
primary diagnoses of SAD and GAD did not moderate
the effects, future studies with larger sample sizes
are needed to determine if differences are specific to
certain anxiety diagnostic groups. Third, the
exploratory analytical approach used in this study
to examine emotion-specific effects was circular (i.e.
nonindependent; for a review, see Kriegeskorte,
Lindquist, Nichols, Poldrack, & Vul, 2010), as the
extracted beta weights for the SFG cluster were
derived from the Match Shape > Match Face con-
trast. Therefore, due to potential noise bias, we
cannot definitively conclude that the current find-
ings were driven by fearful face distractors. Finally,
the study was completed across two sites. Although
our findings did not reveal a significant effect of site
as a moderator, nonspecific factors from each site,
such as patient preference versus random assign-
ment, may have contributed to the findings.
Conclusion
This is the first study to examine the neural corre-
lates of implicit emotion processing in relation to
pediatric anxiety treatment response. The findings
suggest that less recruitment of SFG, including the
dorsal ACC and dorsomedial PFC, during implicit
emotion processing predicts a greater reduction in
anxiety symptoms pre-to-post treatment. Youth who
exhibit reduced activation in these areas while
matching shapes in the context of emotional face
distractors may have more to gain from CBT and
SSRI treatment due to preexisting deficits in
attentional control. These findings suggest that
neuroimaging may be a useful tool for predicting
which youth are most likely to benefit from anxiety
treatment.
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Key points
• Approximately 40%–45% of youth with anxiety disorders do not achieve remission following treatment,
highlighting the need to identify predictors of treatment response.
• This study examined the neural correlates of directing attention toward and away from emotional faces in
relation to pediatric anxiety treatment response.
• Less recruitment of superior frontal gyrus, including the dorsal anterior cingulate cortex, during implicit
emotion processing predicted a greater reduction in anxiety symptoms pre-to-post treatment.
• Youth who exhibit reduced activation in these areas while matching shapes in the context of emotional face
distractors may have more to gain from CBT and SSRI treatment due to preexisting deficits in attentional
control.
• Neuroimaging may be a useful tool for predicting which youth are most likely to benefit from anxiety
treatment.
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